文献速递免疫规划

CHRONOVAC VOYAGEUR:既往接种麻疹疫苗的婴儿对黄热病疫苗免疫应答的研究

CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles.
PubMed 文献 · Vaccine · 2017-09-25

这项回顾性多中心病例对照研究在法国巴黎地区7家旅行门诊开展,比较6-24月龄婴儿在接种麻疹疫苗(单用或联用腮腺炎和风疹疫苗)后1-27天接种黄热病疫苗、同时接种、或间隔超过27天接种时对黄热病疫苗的免疫应答。131名婴儿中127名(96%)具有保护性黄热病抗体滴度,4名无保护性抗体者均属同时接种组;作者认为间隔超过24小时接种时无统计学显著差异,但同时接种时免疫应答似乎降低,结果可能支持修订现行接种建议。

要点

  • 131名婴儿中127名(96%)具有保护性黄热病抗体滴度。
  • 4名无保护性黄热病抗体滴度的婴儿均属于同时接种对照组。
  • 作者认为麻疹疫苗(单用或联用腮腺炎和风疹疫苗)在间隔1-27天时似乎不影响黄热病疫苗的体液免疫应答。

核心结论

  • 作者认为麻疹疫苗单用或联用腮腺炎和风疹疫苗在间隔1-27天接种时似乎不影响黄热病疫苗的体液免疫应答。
  • 无保护性黄热病抗体仅见于同时接种两种疫苗的婴儿。
  • 作者认为结果可能支持修订现行关于这两种减毒活疫苗同日或至少间隔28天接种的建议。
  • 作者指出间隔超过24小时接种时无统计学显著差异,但同时接种时免疫应答似乎降低。

研究设计与样本

  • 回顾性多中心病例对照研究,2011年2月1日至2015年3月31日在巴黎地区7家旅行门诊开展。
  • 研究对象为居住于黄热病非流行国家、旅行前接种过麻疹疫苗和黄热病疫苗的6-24月龄婴儿。
  • 病例定义为接种黄热病疫苗与麻疹疫苗(单用或联用腮腺炎和风疹疫苗)间隔1-27天的婴儿。
  • 对照1为同时接种麻疹疫苗和黄热病疫苗的婴儿,对照2为两种疫苗间隔超过27天的婴儿,按性别和年龄为每例匹配2名对照。
  • 共纳入131名婴儿:病例62名、对照1 50名、对照2 19名。

主要发现

  • 131名婴儿中127名(96%)显示具有保护性黄热病抗体滴度。
  • 4名无保护性黄热病抗体滴度的婴儿均属于对照1(同时接种组)。
  • 作者报告间隔超过24小时接种时无统计学显著差异。

关键数值与推荐

  • 美国免疫实践咨询委员会(ACIP)建议多种减毒活疫苗要么同时接种,要么间隔至少28天,原因是可能降低对任一疫苗的免疫应答。
  • 主要终点为静脉血样本中和抗体滴度所测的保护性黄热病免疫婴儿百分比。

临床怎么用

  • 作者认为结果可能支持修订现行关于这两种减毒活疫苗同日或至少间隔28天接种的建议。
  • 作者认为间隔超过24小时接种时无统计学显著差异,但同时接种时免疫应答似乎降低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: For administration of multiple live attenuated vaccines, the Advisory Committee on Immunization Practices recommends either simultaneous immunization or period of at least 28days between vaccines, due to a possible reduction in the immune response to either vaccine. The main objective of this study was to compare the immune response to measles (alone or combined with mumps and rubella) and yellow fever vaccines among infants aged 6-24months living in a yellow fever non-endemic country who had receivedmeasles and yellow fever vaccines before travelling to a yellow fever endemic area. SUBJECTS AND METHODS: A retrospective, multicenter case-control study was carried out in 7 travel clinics in the Paris area from February 1st 2011 to march 31, 2015. Cases were defined as infants immunized with the yellow fever vaccine and with the measles vaccine, either alone or in combination with mumps and rubella vaccine, with a period of 1-27days between each immunization. For each case, two controls were matched based on sex and age: a first control group (control 1) was defined as infants having received the measles vaccine and the yellow fever vaccine simultaneously; a second control group (control 2) was defined as infants who had a period of more than 27days between receiving the measles vaccine and yellow fever vaccine. The primary endpoint of the study was the percentage of infants with protective immunity against yellow fever, measured by the titer of neutralizing antibodies in a venous blood sample. RESULTS: One hundred and thirty-one infants were included in the study (62 cases, 50 infants in control 1 and 19 infants in control 2). Of these, 127 (96%) were shown to have a protective titer of yellow fever antibodies. All 4 infants without a protective titer of yellow fever antibodies were part of control group 1. DISCUSSION: The measles vaccine, alone or combined with mumps and rubella vaccines, appears to have no influence on humoral immune response to the yellow fever vaccine when administered between 1 and 27days. The absence of protective antibodies against yellow fever was observed only among infants who received both vaccines simultaneously. CONCLUSION: These results may support a revision of current vaccination recommendations concerning the administration of these two live attenuated vaccines either on the same day or at least 28days apart. Our findings show no statistically significant difference if the interval between both vaccines is more than 24 h, but the immune response seems to be reduced when the two vaccines are given at the same time.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Goujon C, Gougeon ML, Tondeur L, et al. CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles. Vaccine. 2017. PMID: 28958813. doi:10.1016/j.vaccine.2017.09.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。